Gain Therapeutics, Inc. Quarterly Operating Leases, Future Minimum Payments Due in USD from Q4 2021 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of required minimum rental payments for leases having an initial or remaining non-cancelable letter-terms in excess of one year.
Summary
Gain Therapeutics, Inc. quarterly Operating Leases, Future Minimum Payments Due history and growth rate from Q4 2021 to Q4 2023.
  • Gain Therapeutics, Inc. Operating Leases, Future Minimum Payments Due for the quarter ending December 31, 2023 was $467K, a 31.9% decline year-over-year.
Operating Leases, Future Minimum Payments Due, Quarterly (USD)
Operating Leases, Future Minimum Payments Due, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $467K -$219K -31.9% Dec 31, 2023 10-K 2024-03-26
Q3 2023 $503K -$197K -28.1% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $577K -$201K -25.9% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $632K -$236K -27.2% Mar 31, 2023 10-Q 2023-05-12
Q4 2022 $686K -$251K -26.8% Dec 31, 2022 10-K 2023-03-23
Q3 2022 $700K Sep 30, 2022 10-Q 2022-11-10
Q2 2022 $778K Jun 30, 2022 10-Q 2022-08-08
Q1 2022 $868K Mar 31, 2022 10-Q 2022-05-16
Q4 2021 $937K Dec 31, 2021 10-K 2022-03-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.